Mochida Pharmaceutical (4534) · TargetRestated
Improving ROE and PBR
First written in FY2025. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Achieving and Sustaining a PBR Above 1xA theme 107 companies write about · 5 as a headwind · 103 as a tailwind
22 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 107 companies compared. The sentences above are computed from all 107.Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「We will balance higher profit levels with investment for future growth and aim to improve ROE and PBR.」
The Company has reaffirmed its financial strategy of seeking to improve ROE and PBR by pursuing both higher profit levels and future investment. - FY2025First statedAnnual report
「We will balance higher profit levels with investment for future growth and aim to improve ROE and PBR.」
As part of the financial strategy under the 25-27 Medium-Term Management Plan, the Company has newly stated the improvement of ROE and PBR as targets through the pursuit of both higher profit levels and future investment.